New
Tirzepatide Peptide Pen
Appetite suppression and insulin sensitivity
- Dual agonist (GLP-1 & GIP) for satiety, blood sugar & weight management
- Supports fat loss, glucose control & metabolic balance
450 €
Well combinable with …
Tirzepatide pairs excellently with the following peptides – depending on your goals:
Tirzepatide is an innovative peptide that activates both GLP-1 and GIP receptors—two key hormones involved in appetite control and blood sugar regulation.
Through this dual action, Tirzepatide promotes intense satiety, improves insulin sensitivity, and significantly reduces body fat percentage.
It is commonly used for obesity, type 2 diabetes, metabolic syndrome, or as part of medically supervised weight management.
Numerous clinical studies demonstrate above-average success in fat loss and long-term weight reduction.
Note: Pen colors may differ from the product image.
Note on the scale:
The numbers on the cartridge (e.g., 20–220) are manufacturer markings and have nothing to do with the dosage.
The correct dose is set exclusively by clicking the pen.
| Weight | 0.5 kg |
|---|---|
| Active ingredient | Tirzepatide |
| Concentration | 8.33 mg/ml |
| Active ingredient per pen | 25 mg |
| Solution | sterile NaCl 0.9% |
| Application | subcutaneous injection via pen system |
This peptide is produced by a specialized peptide laboratory based in the EU. The manufacturer focuses on biotechnological research & sterile peptide formulations.
- Sterile production according to GMP standards
Our peptides are manufactured under pharmaceutical conditions – with documented traceability for each batch. - Lab-tested purity >99%
Each batch is tested for identity, purity and microbial contamination – with COA available upon request. - Product information on every package
Each unit is labeled with batch number, expiration date, and concentration – ensuring maximum transparency. - Climate-protected shipping from Switzerland / EU
We deliver temperature-stable, neutrally packaged, and usually within 24–72 hours.